Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01097707 · ClinicalTrials.gov registry record · Phase 2
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 study, sponsored by Eli Lilly and Company.
- Terminated
- Registry status
- Phase 2
- Development phase
- 414
- Enrollment target
NCT01097707 is a Phase 2 study that was terminated before completion, run by Eli Lilly and Company. The registered enrollment target is 414 participants.
The verdict
NCT01097707, a Phase 2 study, was terminated before completion, sponsored by Eli Lilly and Company.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 414 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether LY500307 helps symptoms of Benign Prostatic Hyperplasia (BPH)
Interventions
- DRUG Placebo
- DRUG LY500307
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 414 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01097707
The ClinicalTrials.gov registry entry for NCT01097707 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 414 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01097707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01097707 about?
NCT01097707 is a clinical study titled "A Study in Men With Benign Prostatic Hyperplasia". The purpose of the study is to determine whether LY500307 helps symptoms of Benign Prostatic Hyperplasia (BPH)
What is the current status of trial NCT01097707?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 414 participants. The study started on 2010-04. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01097707?
The interventions under investigation include: Placebo (DRUG), LY500307 (DRUG).
Who is sponsoring clinical trial NCT01097707?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.